Crossmark Global Holdings Inc. Sells 153 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

Crossmark Global Holdings Inc. trimmed its position in The Cooper Companies, Inc. (NASDAQ:COOFree Report) by 6.5% in the fourth quarter, Holdings Channel reports. The fund owned 2,185 shares of the medical device company’s stock after selling 153 shares during the quarter. Crossmark Global Holdings Inc.’s holdings in Cooper Companies were worth $827,000 at the end of the most recent reporting period.

Several other hedge funds also recently modified their holdings of COO. Tower Research Capital LLC TRC boosted its position in Cooper Companies by 280.3% during the 4th quarter. Tower Research Capital LLC TRC now owns 8,949 shares of the medical device company’s stock worth $3,387,000 after buying an additional 6,596 shares during the period. CIBC Private Wealth Group LLC lifted its holdings in shares of Cooper Companies by 7.2% during the fourth quarter. CIBC Private Wealth Group LLC now owns 4,058 shares of the medical device company’s stock worth $1,536,000 after purchasing an additional 274 shares during the period. NEOS Investment Management LLC bought a new stake in shares of Cooper Companies in the fourth quarter worth $266,000. APG Asset Management US Inc. acquired a new stake in Cooper Companies in the fourth quarter valued at $3,594,000. Finally, California State Teachers Retirement System raised its position in Cooper Companies by 0.9% during the 4th quarter. California State Teachers Retirement System now owns 78,787 shares of the medical device company’s stock worth $29,816,000 after purchasing an additional 738 shares during the last quarter. Institutional investors and hedge funds own 24.39% of the company’s stock.

Cooper Companies Trading Up 0.7 %

NASDAQ:COO opened at $95.08 on Tuesday. The Cooper Companies, Inc. has a 12 month low of $75.93 and a 12 month high of $104.07. The company has a current ratio of 1.95, a quick ratio of 1.14 and a debt-to-equity ratio of 0.34. The stock has a market capitalization of $18.93 billion, a price-to-earnings ratio of 55.85, a PEG ratio of 2.34 and a beta of 1.02. The firm has a fifty day simple moving average of $93.82 and a two-hundred day simple moving average of $94.21.

Cooper Companies (NASDAQ:COOGet Free Report) last issued its earnings results on Thursday, May 30th. The medical device company reported $0.85 EPS for the quarter, beating the consensus estimate of $0.83 by $0.02. Cooper Companies had a return on equity of 8.87% and a net margin of 9.11%. The company had revenue of $942.60 million during the quarter, compared to the consensus estimate of $948.07 million. During the same period last year, the business posted $0.77 EPS. The firm’s revenue for the quarter was up 7.4% compared to the same quarter last year. Analysts expect that The Cooper Companies, Inc. will post 3.57 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

COO has been the subject of several recent research reports. Robert W. Baird increased their price target on Cooper Companies from $116.00 to $118.00 and gave the company an “outperform” rating in a research note on Friday, May 31st. Piper Sandler raised their price target on shares of Cooper Companies from $110.00 to $115.00 and gave the stock an “overweight” rating in a report on Friday, March 1st. Stifel Nicolaus reaffirmed a “buy” rating and issued a $110.00 price objective (up from $105.00) on shares of Cooper Companies in a research note on Friday, March 1st. TheStreet downgraded shares of Cooper Companies from a “b-” rating to a “c” rating in a research note on Thursday, February 29th. Finally, Needham & Company LLC restated a “hold” rating on shares of Cooper Companies in a report on Friday, May 31st. Four analysts have rated the stock with a hold rating and eight have given a buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $111.42.

View Our Latest Analysis on Cooper Companies

Insider Activity

In other Cooper Companies news, CAO Agostino Ricupati sold 54,724 shares of the company’s stock in a transaction on Monday, March 18th. The shares were sold at an average price of $100.89, for a total transaction of $5,521,104.36. Following the transaction, the chief accounting officer now owns 5,081 shares in the company, valued at $512,622.09. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Corporate insiders own 2.00% of the company’s stock.

Cooper Companies Company Profile

(Free Report)

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.

Further Reading

Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cooper Companies, Inc. (NASDAQ:COOFree Report).

Institutional Ownership by Quarter for Cooper Companies (NASDAQ:COO)

Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.